M Müschen Selected Research

M Müschen Research Topics

7	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2016 - 02/2006
5	Leukemia 01/2017 - 02/2006
4	Neoplasms (Cancer) 01/2017 - 01/2000
3	B-Cell Lymphoma (Lymphoma, B Cell) 08/2006 - 06/2006
3	Hodgkin Disease (Hodgkin's Disease) 03/2001 - 02/2001
2	Chromosome Aberrations (Chromosome Abnormalities) 01/2018 - 04/2014
2	Lymphoma (Lymphomas) 08/2006 - 08/2006
2	Breast Neoplasms (Breast Cancer) 08/2000 - 01/2000
1	Cardiotoxicity 01/2017
1	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (Leukemia, Pre B Cell) 04/2014
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 02/2011
1	Hematologic Neoplasms (Hematological Malignancy) 02/2011
1	Philadelphia Chromosome 04/2010
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 06/2006

3	Proteins (Proteins, Gene)FDA Link 08/2006 - 03/2001
3	Fas Ligand Protein (Fas Ligand)IBA 08/2000 - 01/2000
2	Phosphotransferases (Kinase)IBA 02/2011 - 02/2006
2	Tyrosine (L-Tyrosine)FDA Link 02/2011 - 08/2006
2	Pre-B Cell ReceptorsIBA 08/2006 - 08/2006
2	Immunoglobulins (Immunoglobulin)IBA 03/2001 - 02/2001
1	KPT-9274IBA 01/2018
1	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 01/2017
1	Sphingosine-1-Phosphate ReceptorsIBA 01/2017
1	Fingolimod Hydrochloride (FTY720)FDA Link 01/2017
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2017
1	Syk KinaseIBA 01/2016
1	CateninsIBA 04/2014
1	ICG 001IBA 04/2014
1	Pharmaceutical PreparationsIBA 04/2014
1	Dasatinib (BMS 354825)FDA Link 04/2010
1	VDJ RecombinasesIBA 08/2006
1	DNA (Deoxyribonucleic Acid)IBA 08/2006
1	src-Family KinasesIBA 08/2006
1	Immunoglobulin IsotypesIBA 06/2006
1	CD40 Ligand (CD40L)IBA 06/2006
1	Immunoglobulin G (IgG)IBA 06/2006
1	Immunoglobulin M (IgM)IBA 06/2006
1	Imatinib Mesylate (Gleevec)FDA Link 02/2006
1	Transcription Factors (Transcription Factor)IBA 02/2006
1	AntigensIBA 03/2001
1	Codon (Codons)IBA 10/2000
1	Matrix Metalloproteinases (MMPs)IBA 01/2000
1	Interferon-gamma (Interferon, gamma)IBA 01/2000

2	Therapeutics 04/2014 - 02/2006
1	Drug Therapy (Chemotherapy) 06/2006